Doris Coleman
Impact in
- Immunology top 2%
- Immunotherapy and Immune Responses
- T-cell and B-cell Immunology
- Immune Cell Function and Interaction
- Oncology top 5%
- CAR-T cell therapy research
- Cancer Immunotherapy and Biomarkers
Papers in
-
- Immunotherapy and Immune Responses 9
- T-cell and B-cell Immunology 4
- Oncology 8
- CAR-T cell therapy research 5
- Cancer Immunotherapy and Biomarkers 4
- Co-authors
- Eli Gilboa (6 shared papers)Johannes Vieweg (8 shared papers)Donna Yancey (7 shared papers)Jens Dannull (7 shared papers)Donna Niedzwiecki (5 shared papers)Axel Heiser (5 shared papers)Philipp Dahm (7 shared papers)Margaret A. Maurice (4 shared papers)
- Journals
- Journal of Clinical Investigation (3 papers)International Journal of Cancer (1 paper)The Journal of Immunology (1 paper)Cancer Research (1 paper)The Journal of Urology (1 paper)
- Partner nations
- United StatesSpain
In The Last Decade
Doris Coleman
9 papers receiving 1.6k citations
Peers
Comparison fields: 5 of 43
- Immunology 1.3k
- Oncology 676
- Molecular Biology 814
- Biotechnology 81
- Genetics 247
Countries citing papers authored by Doris Coleman
This map shows the geographic impact of Doris Coleman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Doris Coleman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Doris Coleman more than expected).
Fields of papers citing papers by Doris Coleman
This network shows the impact of papers produced by Doris Coleman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Doris Coleman. The network helps show where Doris Coleman may publish in the future.
Co-authors
The 17 scholars most cited alongside Doris Coleman, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2002 | 420 | |
| 2 | 2002 | 386 | |
| 3 | Immunological and clinical responses in metastatic renal cancer patients vaccinated with tumor RNA-transfected dendritic cells. | 2003 | 289 |
| 4 | 2005 | 274 | |
| 5 | 1999 | 141 | |
| 6 | Human dendritic cells transfected with renal tumor RNA stimulate polyclonal T-cell responses against antigens expressed by primary and metastatic tumors. | 2001 | 123 |
| 7 | 2002 | 23 | |
| 8 | In situ Activation of Dendritic Cells (DC) with Imiquimod for Cancer Immunotherapy | 2006 | 7 |
| 9 | 2006 | 2 |
About Doris Coleman
Doris Coleman is a scholar working on Immunology, Oncology, Molecular Biology, Surgery and Infectious Diseases, having authored 9 papers that have together received 1.7k indexed citations. Recurring topics across this work include Immunotherapy and Immune Responses (9 papers), CAR-T cell therapy research (5 papers), Cancer Immunotherapy and Biomarkers (4 papers), T-cell and B-cell Immunology (4 papers), RNA Interference and Gene Delivery (2 papers), vaccines and immunoinformatics approaches (1 paper), Renal and related cancers (1 paper) and Bladder and Urothelial Cancer Treatments (1 paper). The work is most often cited by research in Immunology (1.3k citations), Oncology (676 citations), Molecular Biology (814 citations), Biotechnology (81 citations) and Genetics (247 citations). Doris Coleman has collaborated with scholars based in United States and Spain. Frequent co-authors include Eli Gilboa, Johannes Vieweg, Donna Yancey, Jens Dannull, Donna Niedzwiecki, Axel Heiser, Philipp Dahm, Margaret A. Maurice, Costas D. Lallas and Zhen Su. Their work appears in journals such as Journal of Clinical Investigation, International Journal of Cancer, The Journal of Immunology, Cancer Research and The Journal of Urology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.